Skip to content
Sexuality – Lifestyle
Author:
MAHZI Therapeutics
Mahzi Therapeutics Announces FDA Rare Pediatric Disease Designation for MZ-1866 Investigational Therapy for Pitt Hopkins Syndrome
August 25, 2026